Brain Scientific Appoints Two Senior Executives to Lead Revenue Generation Efforts
Brain Scientific Appoints Two Senior Executives to Lead Revenue Generation Efforts
Felicia Maher, VP of Medical Product Sales, and Todd Bertrand, VP of Motion Products Sales, will manage Brain Scientific's revenue growth
醫療產品銷售副總裁Felicia Maher和運動產品銷售副總裁Todd Bertrand將管理Brain Science的收入增長
LAKEWOOD RANCH, Fla., March 17, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific (OTCQB:BRSF) today announces the appointments of Felicia Maher as VP of Sales for Medical Products and Todd Bertrand as VP of Sales for Motion Products.
2022年3月17日，佛羅裏達州萊克伍德牧場(Global Newswire)--Via InvestorWire-Brain Science(場外交易市場代碼：BRSF)今天宣佈任命Felicia Maher為醫療產品銷售副總裁，Todd Bertrand為Motion Products銷售副總裁。
To manage the surging demand for Brain Scientific's innovative products, Felicia will handle all sales and marketing initiatives for the company's medical line while Todd will oversee the expansion of the motion products distributor network.
為了管理對Brain Science創新產品激增的需求，Felicia將負責該公司醫療線的所有銷售和營銷活動，而Todd將負責Motion Products分銷網絡的擴展。
"The NeuroCap and NeuroEEG are truly disruptive, and the company has a great strategy to build a neurology diagnostics platform," said Felicia Maher. "I am eager to work with the Brain Scientific team to grow current sales channels and deliver their revolutionary medical devices worldwide."
“NeuroCap和NeuroEEG確實是顛覆性的，該公司有一個偉大的戰略來建立一個神經學診斷平臺，”Felicia Maher説。我渴望與腦科學團隊合作，擴大目前的銷售渠道，並在全球範圍內提供他們革命性的醫療設備。“
"It has been fantastic to see the interest in our unique, precision motors from both partners and customers," said Todd Bertrand. "There is nothing in the market today like our tiny, efficient motors; they are an ideal choice for robotic surgery and small, compact drug-delivery devices."
Todd Bertrand説：“看到合作伙伴和客户對我們獨特的精密電機的興趣，這真是太棒了。”今天的市場上沒有什麼比我們的微型高效馬達更好的了；它們是機器人手術和小型緊湊型藥物輸送設備的理想選擇。
"Felicia and Todd are both seasoned sales executives, and we are very fortunate to have their experience and track records leading our sales efforts," said Hassan Kotob, chairman and CEO of Brain Scientific. "I am confident that they will manage and secure our global sales expansion."
Brain Science董事長兼首席執行官Hassan Kotob表示：“Felicia和Todd都是經驗豐富的銷售主管，我們非常幸運能有他們的經驗和業績記錄來領導我們的銷售工作。”我相信，他們將管理和確保我們的全球銷售擴張。“
Felicia Maher, VP of Medical Products
Felicia Maher，醫療產品副總裁
Felicia brings extensive revenue management experience and over 17 years of launching, marketing and growing sales for high-tech devices and platforms in the medical field. She has held various positions including Director of Sales at A&D Engineering, where she managed relationships including the Veteran's Affairs and Department of Defense, as well as Senior Regional Sales Manager at Medtronic, a leading medical device manufacturer. She has both domestic and international sales experience in the medical device market and will leverage her full experience and network to rapidly scale our medical product sales.
Felicia擁有豐富的收入管理經驗，並在醫療領域的高科技設備和平臺方面擁有17年的推出、營銷和不斷增長的銷售經驗。她曾擔任過多個職位，包括A&D Engineering的董事銷售，在那裏她管理着包括退伍軍人事務部和國防部在內的各種關係，以及在領先的醫療器械製造商美敦力擔任高級區域銷售經理。她在醫療器械市場擁有國內和國際銷售經驗，並將利用她的全面經驗和網絡迅速擴大我們的醫療產品銷售。
Todd Bertrand, VP of Motion Products
運動產品副總裁託德·伯特朗
Todd brings a successful background generating business in technology industries to our team. Todd has been in sales management for over 20 years, including at Emerson Industrial Automation and A&D Engineering, where he previously met and worked with Felicia. He has experience growing sales for technologies across the value chain, from drives and motion control systems to finished machines and system/process sales. Todd likewise has both international and US experience, having been responsible for sales across Canada, the US, and LATAM in prior positions. At Piezo Motion, he has already signed more than 15 distributors as well as collaborated directly with customers to meet their specific needs across off-the-shelf orders and custom projects.
託德為我們的團隊帶來了成功的背景，創造了科技行業的業務。託德從事銷售管理已有20多年，包括在艾默生工業自動化和A&D工程公司工作，在那裏他與Felicia相識並共事。從驅動和運動控制系統到成品機器和系統/過程銷售，他在整個價值鏈的技術銷售方面擁有不斷增長的經驗。託德同樣擁有國際和美國的經驗，曾負責加拿大、美國和LATAM地區的銷售。在Piezo Motion，他已經與15家以上的分銷商簽約，並直接與客户合作，以滿足他們在現成訂單和定製項目中的特定需求。
About Brain Scientific
關於腦科學
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.
Brain Science是一家擁有多項專利和FDA批准產品的醫療技術公司。Brain Science致力於開發下一代解決方案，以推動神經診斷和OEM醫療設備的未來。Brain Science有兩個產品線，涵蓋神經學和精密運動。NeuroCap和NeuroEEG是智能神經診斷設備，可以簡化管理、縮短掃描時間並降低成本。Piezo Motion產品線由超高效緊湊型精密電機組成，將驅動下一代醫療設備。欲瞭解有關Brain Science公司的公司戰略、產品或投資者關係的更多信息，請訪問BrainScience網站。
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
前瞻性陳述
本新聞稿中包含的任何不描述歷史事實的陳述都可能構成前瞻性陳述。前瞻性陳述可能包括但不限於以下陳述：(I)未來業務的管理計劃和目標，包括與腦電產品和服務以及壓電電機技術的設計、開發和商業化有關的計劃或目標；(Ii)收入(包括收入/虧損)、每股收益(包括收益/虧損)、資本支出、股息、資本結構或其他財務項目的預測；(Iii)公司未來的財務表現；(Iv)Piezo Motion與Brain Science的成功整合；以及(V)以上第(I)、(Ii)、(Iii)或(Iv)點所述任何陳述所依據的或與之有關的假設。此類前瞻性陳述不是為了預測或保證實際結果、業績、事件或情況，也可能無法實現，因為它們是基於公司目前的預測、計劃、目標、信念、預期、估計和假設，受許多風險、不確定性和其他影響的影響，其中許多是公司無法控制的。由於這些風險和不確定性，某些事件和情況的實際結果和時間可能與前瞻性陳述中描述的大不相同。可能影響或導致前瞻性陳述不準確或導致實際結果與預期或期望結果大不相同的因素可能包括但不限於, 該公司無法獲得更多融資；與開發產品和相關產品相關的時間和資源過長；現金流不足和由此導致的流動性不足；該公司無法擴大其業務；政府對醫療器械和醫療保健行業的監管力度較大；缺乏產品多元化；該公司原材料價格波動；以及未能實施該公司的業務計劃或戰略。在該公司提交給美國證券交易委員會的文件中，對其中一些因素以及其他一些因素進行了識別和更詳細的描述。該公司不承諾更新這些前瞻性陳述。
CONTACTS
觸點
INVESTORS
ir@brainscientific.com
投資商
郵箱：ir@brainScience fic.com
MEDIA
pr@brainscientific.com
媒體
電子郵箱：pr@brainScience fic.com
Corporate Communications
企業通信
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
IBN(InvestorBrandNetwork)
加利福尼亞州洛杉磯
310.299.1717辦公室
郵箱：EDITOR@InvestorBrandNetwork.com
譯文內容由第三人軟體翻譯。